Biochemical Pharmacology volume 82, issue 2, P99-109 2011 DOI: 10.1016/j.bcp.2011.03.027 View full text
|
|
Share
Erik De Clercq

Abstract: ABSTRACTThe use of the acyclic nucleoside phosphonates, starting with (S)-HPMPA as the prototype, yielded three clinically approved antiviral drugs, cidofovir for the treatment of CMV retinitis in AIDS patients, adefovir dipivoxil for the treatment of chronic hepatitis B and tenofovir disoproxil fumarate for the treatment of HIV infections (AIDS) and HBV infections. This era has now grown to many more acyclic (and cyclic) nucleoside phosphonates (such as the "open ring" DAPy and Fd4A phosphonates) and alkoxya…

expand abstract